Denosumab vs Risedronate in Glucocorticoid-Induced Osteoporosis: Final Results of a 24-Month Randomized, Double-Blind, Double-Dummy Trial
Arthritis and Rheumatology - United Kingdom
doi 10.1002/art.40874
Full Text
Open PDFAbstract
Available in full text
Date
May 25, 2019
Authors
Publisher
Wiley